What is the effect of afatinib in India and how to judge its effectiveness?

Afatinib, a targeted drug for lung cancer, is a new generation of oral tyrosine kinase inhibitor and the first irreversible ErbB family blocker. Its effect on rare EGFR mutations is particularly significant, mainly for common EGFR mutations, and afatinib for rare mutation HER2. Afatinib is an excellent anti-cancer drug, which has a significant effect on non-small cell lung cancer. So far, the number of patients who have benefited from it is still increasing.

What is the effect of afatinib in India?

Afatinib is the first irreversible inhibitor, which can irreversibly bind to ERBB family receptors, block downstream information transmission and prevent cancer cells from developing. Blocking the signal pathway of cancer cells can achieve the purpose of inhibiting tumor growth. At present, clinical data show that the therapeutic effect of afatinib on lung squamous cell carcinoma is also outstanding, which can obviously delay the progress of lung squamous cell carcinoma and reduce the risk of cancer progress19%; Therefore, it can significantly prolong the overall survival time of patients and reduce the risk of death 19%. In addition, afatinib can significantly improve the disease control rate and improve the quality of life of patients. Afatinib from India, which is sought after in the market at present, is no different from the original factory in terms of target and total curative effect.

How to judge the effectiveness of afatinib

The treatment of lung cancer usually takes a long time, and targeted drugs are no exception. Whether alfatinib is effective or not can only be seen after long-term administration. Generally, when there is a target corresponding to afatinib, patients will feel their physical symptoms relieved after taking 10 for about 0 days. Most patients will choose to go to the hospital for reexamination after taking it for one month, but each patient's physical quality and condition are different. If you are a blind patient who tries afatinib, the effect may not be quick. Patients should not be too impatient, but patients who are preparing for blind examination must also use it under the advice of the attending doctor. If there is no disease targeted by afatinib, it will not be effective. The onset time of targeted drugs is generally slower than chemotherapy drugs. Therefore, the specific onset time after taking afatinib varies from person to person. Indekang Medical said that if patients take afatinib for a period of time, their body surface symptoms will be significantly improved, such as pain relief, cough reduction and mental improvement. It can be preliminarily judged that afatinib is effective. If further diagnosis is needed, you need to go to the hospital for CT examination. If the results show that the disease has not continued to grow or has begun to shrink gradually, it can be confirmed that afatinib is effective for patients.